Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2
Authors
Li, WenhuiGreenough, Thomas C.
Moore, Michael J.
Vasilieva, Natalya
Somasundaran, Mohan
Sullivan, John L.
Farzan, Michael
Choe, Hyeryun
Document Type
Journal ArticlePublication Date
2004-10-01Keywords
3T3 CellsAnimals
Cell Line
Endopeptidases
Humans
Mice
Peptidyl-Dipeptidase A
Rats
SARS Virus
Severe Acute Respiratory Syndrome
*Virus Replication
Immunology and Infectious Disease
Pediatrics
Metadata
Show full item recordAbstract
Replication of viruses in species other than their natural hosts is frequently limited by entry and postentry barriers. The coronavirus that causes severe acute respiratory syndrome (SARS-CoV) utilizes the receptor angiotensin-converting enzyme 2 (ACE2) to infect cells. Here we compare human, mouse, and rat ACE2 molecules for their ability to serve as receptors for SARS-CoV. We found that, compared to human ACE2, murine ACE2 less efficiently bound the S1 domain of SARS-CoV and supported less-efficient S protein-mediated infection. Rat ACE2 was even less efficient, at near background levels for both activities. Murine 3T3 cells expressing human ACE2 supported SARS-CoV replication, whereas replication was less than 10% as efficient in the same cells expressing murine ACE2. These data imply that a mouse transgenically expressing human ACE2 may be a useful animal model of SARS.Source
J Virol. 2004 Oct;78(20):11429-33. Link to article on publisher's siteDOI
10.1128/JVI.78.20.11429-11433.2004Permanent Link to this Item
http://hdl.handle.net/20.500.14038/43459PubMed ID
15452268Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1128/JVI.78.20.11429-11433.2004